CDW (NASDAQ: CDW) insider transactions
In the twelve months to 10 November 2026, executives and directors of CDW reported 2 open-market sales of 34,095 shares ($4.8m) and 2 open-market purchases of 22,830 shares ($2.5m), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 15 October 2026 | Balaji Saranga | Director | Grant or award | +504 | — | 504 | Form 4 |
| 1 October 2026 | Nelms David W | Director | Grant or award | +258 | — | 51,821 | Form 4 |
| 1 October 2026 | Swedish Joseph | Director | Grant or award | +212 | — | 20,444 | Form 4 |
| 24 September 2026 | Sanderson Katherine Elizabeth | See Remarks | Shares withheld for tax | −232 | $153.74 | 24,511 | Form 4 |
| 10 September 2026 | Bell James A | Director | Grant or award | +96 | $142.60 | 26,454 | Form 4 |
| 10 September 2026 | Connelly Elizabeth H. | See Remarks | Grant or award | +238 | $142.60 | 34,453 | Form 4 |
| 10 September 2026 | Grier Kelly J | Director | Grant or award | +7 | $142.60 | 4,069 | Form 4 |
| 10 September 2026 | Swedish Joseph | Director | Grant or award | +29 | $142.60 | 20,232 | Form 4 |
| 10 September 2026 | Leahy Christine A | See Remarks | Grant or award | +825 | $142.60 | 194,480 | Form 4 |
| 10 September 2026 | Locy Peter R | See Remarks | Grant or award | +29 | $142.60 | 5,951 | Form 4 |
| 10 September 2026 | Miralles Albert Joseph JR | See Remarks | Grant or award | +299 | $142.60 | 47,644 | Form 4 |
| 10 September 2026 | Foxx Anthony R | Director | Grant or award | +30 | $142.60 | 6,758 | Form 4 |
| 10 September 2026 | Tan Hang | See Remarks | Grant or award | +213 | $142.60 | 34,179 | Form 4 |
| 10 September 2026 | Clarizio Lynda M | Director | Grant or award | +7 | $142.60 | 15,748 | Form 4 |
| 10 September 2026 | Kulevich Frederick J. | See Remarks | Grant or award | +185 | $142.60 | 44,825 | Form 4 |
| 10 September 2026 | Sanderson Katherine Elizabeth | See Remarks | Grant or award | +243 | $142.60 | 24,743 | Form 4 |
| 10 September 2026 | Addicott Virginia C. | Director | Grant or award | +82 | $142.60 | 18,675 | Form 4 |
| 10 September 2026 | Kumar Mukesh | See Remarks | Grant or award | +192 | $142.60 | 20,723 | Form 4 |
| 10 September 2026 | Nelms David W | Director | Grant or award | +148 | $142.60 | 51,563 | Form 4 |
| 10 September 2026 | Jones Marc Ellis | Director | Grant or award | +20 | $142.60 | 4,533 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the CDW page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.